CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO acquired 166,667 shares (grant or award)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 5,000 shares at $3.50 ($17,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO acquired 166,667 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 5,000 shares at $3.83 ($19,150)
- 4 Open-market buy GENERAL COUNSEL bought 3,000 shares at $3.60 ($10,800)
- 4/A Insider Changes in Ownership
- 4 Open-market buy CEO bought 9,800 shares at an average $3.59 ($35,163)
Page 8 of 20 · 384 filings